The United States has announced a 100% tariff on Indian pharmaceutical imports, deepening trade tensions between the two countries. US President Donald Trump made the announcement on his social media platform, Truth Social. The new tariff will take effect from October 1. However, Trump said companies opening drug manufacturing plants in the US will be exempt. He cited national security as the main reason for the decision.
India is among the world’s largest exporters of generic medicines, and the move could hit its economy hard. According to Indian media, India exports around $10 billion worth of pharmaceutical products to the US annually. More than one-third of medicines used in the US are imported from India. The 100% tariff could cause price hikes and supply chain disruptions in both countries. It may also force Indian exporters to find new markets.
Read more: Trump criticizes India’s late tariff cut offer, calls trade one-sided
Alongside medicines, the US has also imposed tariffs on several other Indian products. Kitchen cabinets and bathroom vanities now face a 50% duty. Furniture imports have been hit with a 30% tariff, while heavy-duty trucks will see a 25% tariff. These measures show the US government’s growing focus on reshaping trade policies. It also signals a tougher approach towards countries with large trade surpluses.
The decision comes amid already strained ties between the two nations. Over the past few months, relations between the US and India have cooled. The earlier 50% tariffs on Indian goods had already hurt exports. Now, the new round of tariffs could further damage trade and diplomatic relations. Indian officials have not yet issued a formal response to the latest action.
Read more: Trump says India offered to reduce tariffs on US goods to nothing
Experts believe the move could have long-term consequences for India’s export-driven industries. Pharmaceutical companies may lose their biggest market and face reduced earnings. At the same time, US consumers might see increased prices for essential medicines. The situation may also open doors for negotiations, if both sides decide to ease tensions. For now, the pressure on India’s economy is likely to increase.